-+ 0.00%
-+ 0.00%
-+ 0.00%

DA Davidson Maintains Buy on Cellebrite DI, Lowers Price Target to $15

Benzinga·08/14/2026 13:57:24
Listen to the news
DA Davidson analyst Rudy Kessinger maintains Cellebrite DI (NASDAQ:CLBT) with a Buy and lowers the price target from $22 to $15.